Tools for the analysis and characterization of therapeutic protein species

References

• Walsh G. Biopharmaceutical benchmarks 2010. Nat Biotechnol. 2010;28(9):917–924. doi: 10.1038/nbt0910–0917.
   Web of Science ®Google Scholar
• Carter PJ. Introduction to current and future protein therapeutics: A protein engineering perspective. Exp Cell Res. 2011;317(9):1261–1269.
   PubMed Web of Science ®Google Scholar
• Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32(10):992–1000.
   PubMed Web of Science ®Google Scholar
• Lad L, Clancy S, Kovalenko M, et al. High-throughput kinetic screening of hybridomas to identify high-affinity antibodies using bio-layer interferometry. J Biomol Screen. 2015;20(4):498–507.
   Google Scholar
• Jacobs PP, Callewaert N. N-glycosylation engineering of biopharmaceutical expression systems. Curr Mol Med. 2009;9(7):774–800.
   PubMed Web of Science ®Google Scholar
• Shukla AA, Jiang C, Ma J, Rubacha M, Flansburg L, Lee SS. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Biotechnol Prog. 2008;24(3):615–622. doi: 10.1021/bp070396j. Epub 2008 Apr 15.
   Web of Science ®Google Scholar
• Aboulaich N, Chung WK, Thompson JH, Larkin C, Robbins D, Zhu M. A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies. Biotechnology Prog. 2014; 30(5):1114–1124.
   Web of Science ®Google Scholar
• Mihara K, Ito Y, Hatano Y, et al. Host cell proteins: the hidden side of biosimilarity assessment. J Pharm Sci. 2015;104(12):3991–3996.
   Web of Science ®Google Scholar
• Bracewell DG, Francis R, Smales CM. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control. Biotechnol Bioeng. 2015;112(9):1727–1737.
   PubMed Web of Science ®Google Scholar
• Blackstone EA, Joseph PF. The economics of biosimilars. Am Health Drug Benefits. 2013;6(8):469–478.
   PubMedGoogle Scholar
• Blackstone EA, Fuhr JP, Jr. Innovation and competition: will biosimilars succeed? The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety. Biotechnol Healthc. 2012;9(1):24–27.
   PubMedGoogle Scholar
• Beck A, Debaene F, Diemer H, et al. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J Mass Spectrom. 2015;50(2):285–297. doi: 10.1002/jms.3554.
   PubMed Web of Science ®Google Scholar
• Tsiftsoglou AS, Ruiz S, Schneider CK. Development and regulation of biosimilars: current status and future challenges. Bio Drugs. 2013; 27(3):203–211.
   Google Scholar
• Thelwell C, Longstaff C. Biosimilars: the process is the product. The example of recombinant streptokinase. J Thromb Haemost. 2014;12(8):1229–1233.
   Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianferani S. Characterization of therapeutic antibodies and related products. Anal Chem. 2013;85(2):715–736.
   PubMed Web of Science ®Google Scholar
• Staub A, Guillarme D, Schappler J, Veuthey JL, Rudaz S. Intact protein analysis in the biopharmaceutical field. J Pharm Biomed Anal. 2011;55(4):810–822.
   PubMed Web of Science ®Google Scholar
• Sandra K, Vandenheede I, Sandra P. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. J Chromatogr A. 2014;1335:81–103.
   PubMed Web of Science ®Google Scholar
• Levy NE, Valente KN, Choe LH, Lee KH, Lenhoff AM. Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing. Biotechnol Bioeng. 2014;111(5):904–912.
   Web of Science ®Google Scholar
• Buyel JF, Twyman RM, Fischer R. Extraction and downstream processing of plant-derived recombinant proteins. Biotechnol Adv. 2015; 33(6 Pt 1):902–913.
   Web of Science ®Google Scholar
• Wang X, Hunter AK, Mozier NM. Host cell proteins in biologics development: identification, quantitation and risk assessment. Biotechnol Bioeng. 2009;103(3):446–458.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wu M, Menesale E, Lu T, Magliola A, Bergelson S. Development and qualification of a high sensitivity, high throughput Q-PCR assay for quantitation of residual host cell DNA in purification process intermediate and drug substance samples. J Pharm Biomed Anal. 2014;100:145–149.
   PubMed Web of Science ®Google Scholar
• Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov. 2008;7(1):21–39.
   PubMed Web of Science ®Google Scholar
• Bomans K, Lang A, Roedl V, et al. Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing. PLoS One. 2013;8(11):e81639.
   Web of Science ®Google Scholar
• Tscheliessnig AL, Konrath J, Bates R, Jungbauer A. Host cell protein analysis in therapeutic protein bioprocessing – methods and applications. Biotechnol J. 2013;8(6):655–670.
   PubMed Web of Science ®Google Scholar
• Zhu-Shimoni J, Yu C, Nishihara J, et al. Host cell protein testing by ELISAs and the use of orthogonal methods. Biotechnol Bioeng. 2014;111(12):2367–2379.
   PubMed Web of Science ®Google Scholar
• Xu D, Mane S, Sosic Z. Characterization of a biopharmaceutical protein and evaluation of its purification process using automated capillary Western blot. Electrophoresis. 2015;36(2):363–370.
   Web of Science ®Google Scholar
• Schenauer MR, Flynn GC, Goetze AM. Identification and quantification of host cell protein impurities in biotherapeutics using mass spectrometry. Anal Biochem. 2012;428(2):150–157.
   PubMed Web of Science ®Google Scholar
• Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 2012;30(1):210–222.
   PubMed Web of Science ®Google Scholar
• Shapiro HM. Multiparameter flow cytometry of bacteria: implications for diagnostics and therapeutics. Cytometry. 2001;43(3):223–226.
   Google Scholar
• Reisinger V, Toll H, Mayer RE, Visser J, Wolschin F. A mass spectrometry-based approach to host cell protein identification and its application in a comparability exercise. Anal Biochem. 2014;463:1–6.
   PubMed Web of Science ®Google Scholar
• He Y, Isele C, Hou W, Ruesch M. Rapid analysis of charge variants of monoclonal antibodies with capillary zone electrophoresis in dynamically coated fused-silica capillary. J Sep Sci. 2011;34(5):548–555.
   PubMed Web of Science ®Google Scholar
• Redman EA, Batz NG, Mellors JS, Ramsey JM. Integrated microfluidic capillary electrophoresis-electrospray ionization devices with online MS detection for the separation and characterization of intact monoclonal antibody variants. Anal Chem. 2015;87(4):2264–2272.
   PubMed Web of Science ®Google Scholar
• Hogwood CEM, Bracewell DG, Smales CM. Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses. Curr Opin Biotechnol. 2014;30:153–160.
   PubMed Web of Science ®Google Scholar
• Vihinen M. Types and effects of protein variations. Hum Genet. 2015;134(4):405–421.
   Web of Science ®Google Scholar
• Herring LE, Grant KG, Blackburn K, Haugh JM, Goshe MB. Development of a tandem affinity phosphoproteomic method with motif selectivity and its application in analysis of signal transduction networks. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;988:166–174.
   Web of Science ®Google Scholar
• Lynaugh H, Li H, Gong B. Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry. MAbs. 2013;5(5):641–645.
   PubMed Web of Science ®Google Scholar
• Roth Z, Yehezkel G, Khalaila I. Identification and quantification of protein glycosylation. Int J Carbohydr Chem. 2012:10.
   Google Scholar
• Hua S, Nwosu CC, Strum JS, et al. Site-specific protein glycosylation analysis with glycan isomer differentiation. Anal Bioanal Chem. 2012;403(5):1291–1302.
   PubMed Web of Science ®Google Scholar
• Li Y, Silva JC, Skinner ME, Lombard DB. Mass spectrometry- based detection of protein acetylation. Methods Mol Biol. 2013; 1077:81–104.
   Google Scholar
• Wiggins B, Liu-Shin L, Yamaguchi H, Ratnaswamy G. Characterization of cysteine-linked conjugation profiles of immunoglobulin g1 and immunoglobulin g2 antibody-drug conjugates. J Pharm Sci. 2015;104(4):1362–1372.
   PubMed Web of Science ®Google Scholar
• Marcoux J, Champion T, Colas O, et al. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate. Protein Sci. 2015;24(8):1210–1223.
   PubMed Web of Science ®Google Scholar
• Debaene F, Boeuf A, Wagner-Rousset E, et al. Innovative native MS methodologies for antibody drug conjugate characterization: high resolution native MS and IM-MS for average DAR and DAR distribution assessment. Anal Chem. 2014;86(21):10674–10683.
   PubMed Web of Science ®Google Scholar
• Barnett GV, Qi W, Amin S, et al. Structural changes and aggregation mechanisms for anti-streptavidin IgG1 at elevated concentration. J Phys Chem B. 2015;119(49):15150–15163.
   Web of Science ®Google Scholar
• Yu CM, Mun S, Wang NH. Phenomena of insulin peak fronting in size exclusion chromatography and strategies to reduce fronting. J Chromatogr A. 2008;1192(1):121–129.
   PubMed Web of Science ®Google Scholar
• Hong P, Koza S, Bouvier ES. Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J Liq Chromatogr Relat Technol. 2012;35(20):2923–2950.
   PubMed Web of Science ®Google Scholar
• Iavicoli P, Urban P, Bella A, Ryadnov MG, Rossi F, Calzolai L. Application of asymmetric flow field-flow fractionation hyphenations for liposome-antimicrobial peptide interaction. J Chromatogr A. 2015;1422:260–269.
   Web of Science ®Google Scholar
• Kashid SB, Tak RD, Raut RW. Antibody tagged gold nanoparticles as scattering probes for the pico molar detection of the proteins in blood serum using nanoparticle tracking analyzer. Colloids Surf B Biointerfaces. 2015;133:208–213.
   Web of Science ®Google Scholar
• Chen X, Choudhari SP, Kumar P, et al. Biophysical characterization of the Type III secretion system translocator proteins and the translocator proteins attached to bacterium-like particles. J Pharm Sci. 2015;104(12):4065–4073.
   Web of Science ®Google Scholar
• Safari MS, Vorontsova MA, Poling-Skutvik R, Vekilov PG, Conrad JC. Differential dynamic microscopy of weakly scattering and polydisperse protein-rich clusters. Phys Rev E Stat Nonlin Soft Matter Phys. 2015;92(4):042712.
   Web of Science ®Google Scholar
• McCamish M, Woollett G. The state of the art in the development of biosimilars. Clin Pharmacol Ther. 2012;91(3):405–417.
   PubMed Web of Science ®Google Scholar
• Rustandi RR, Wang F, Hamm C, Cuciniello JJ, Marley ML. Development of imaged capillary isoelectric focusing method and use of capillary zone electrophoresis in hepatitis B vaccine RECOMBIVAX HB(R). Electrophoresis. 2014;35(7):1072–1078.
   Web of Science ®Google Scholar
• Rustandi RR, Peklansky B, Anderson CL. Use of imaged capillary isoelectric focusing technique in development of diphtheria toxin mutant CRM197. Electrophoresis. 2014;35(7):1065–1071.
   Web of Science ®Google Scholar
• Anderson CL, Wang Y, Rustandi RR. Applications of imaged capillary isoelectric focussing technique in development of biopharmaceutical glycoprotein-based products. Electrophoresis. 2012;33(11):1538–1544.
   Web of Science ®Google Scholar
• Stoll DR, Harmes DC, Danforth J, et al. Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography-mass spectrometry. Anal Chem. 2015;87(16):8307–8315.
   PubMed Web of Science ®Google Scholar
• Uliyanchenko E. Size-exclusion chromatography-from high-performance to ultra-performance. Anal Bioanal Chem. 2014;406(25):6087–6094.
   Web of Science ®Google Scholar
• Brower KP, Ryakala VK, Bird R, et al. Single-step affinity purification of enzyme biotherapeutics: a platform methodology for accelerated process development. Biotechnol Prog. 2014;30(3):708–717.
   PubMed Web of Science ®Google Scholar
• Silva AM, Vitorino R, Domingues MR, Spickett CM, Domingues P. Post-translational modifications and mass spectrometry detection. Free Radic Biol Med. 2013;65:925–941.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang F, Ye M, Zou H. Enrichment and separation techniques for large-scale proteomics analysis of the protein post-translational modifications. J Chromatogr A. 2014;1372C:1–17.
   Web of Science ®Google Scholar
• Le Fourn V, Girod PA, Buceta M, Regamey A, Mermod N. CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metab Eng. 2014;21:91–102.
   PubMed Web of Science ®Google Scholar
• Zhao SS, Chen DD. Applications of capillary electrophoresis in characterizing recombinant protein therapeutics. Electrophoresis. 2014;35(1):96–108.
   PubMed Web of Science ®Google Scholar
• Qiu F, Hou T, Huang D, et al. Evaluation of two high-abundance protein depletion kits and optimization of downstream isoelectric focusing. Mol Med Rep. 2015;12(5):7749–7755.
   Web of Science ®Google Scholar
• Tipton JD, Tran JC, Catherman AD, Ahlf DR, Durbin KR, Kelleher NL. Analysis of intact protein isoforms by mass spectrometry. J Biol Chem. 2011;286(29):25451–25458.
   PubMed Web of Science ®Google Scholar
• Zhang H, Cui W, Gross ML. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies. FEBS Lett. 2014;588(2):308–317.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huttenhain R, Collins B, Aebersold R. Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev Mol Diagn. 2013;13(8):811–825.
   PubMed Web of Science ®Google Scholar
• Sajic T, Liu Y, Aebersold R. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications. Proteomics Clin Appl. 2015;9(3–4):307–321.
   PubMed Web of Science ®Google Scholar
• Orellana CA, Marcellin E, Schulz BL, Nouwens AS, Gray PP, Nielsen LK. High-antibody-producing Chinese hamster ovary cells up-regulate intracellular protein transport and glutathione synthesis. J Proteome Res. 2015;14(2):609–618.
   Web of Science ®Google Scholar
• Zhang Z, Pan H, Chen X. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev. 2009;28(1):147–176.
   PubMed Web of Science ®Google Scholar
• van den Broek I, Niessen WM, van Dongen WD. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;929:161–179.
   PubMed Web of Science ®Google Scholar
• Mao Y, Valeja SG, Rouse JC, Hendrickson CL, Marshall AG. Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry. Anal Chem. 2013;85(9):4239–4246.
   PubMed Web of Science ®Google Scholar
• Thompson NJ, Rosati S, Heck AJ. Performing native mass spectrometry analysis on therapeutic antibodies. Methods. 2014;65(1):11–17.
   PubMed Web of Science ®Google Scholar
• Lanucara F, Holman SW, Gray CJ, Eyers CE. The power of ion mobility-mass spectrometry for structural characterization and the study of conformational dynamics. Nat Chem. 2014;6(4):281–294.
   PubMed Web of Science ®Google Scholar
• Wang D, Wynne C, Gu F, et al. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry. Anal Chem. 2015;87(2):914–921.
   Web of Science ®Google Scholar
• Johnson CM. Differential scanning calorimetry as a tool for protein folding and stability. Arch Biochem Biophys. 2013;531(1–2):100–109.
   PubMed Web of Science ®Google Scholar
• Chiu MH, Prenner EJ. Differential scanning calorimetry: an invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. J Pharm Bioallied Sci. 2011;3(1):39–59.
   PubMedGoogle Scholar